Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 137 (GPR137) is an integral membrane protein that functions as a cell surface receptor. It belongs to the GPCR superfamily and mediates signal transduction processes involved in cell growth, cell cycle regulation, and apoptosis. GPR137 is expressed in various tissues, notably in the brain, kidney, liver, and is highly expressed in certain cancer cell lines. Recent studies show that silencing GPR137 inhibits cell proliferation and triggers apoptosis in leukemia and gastric cancer cells, identifying it as a promising therapeutic target and biomarker for cancer diagnosis and therapy. GPR137 has three splice isoforms (GPR137A, GPR137B, and GPR137C), of which GPR137A is most often referenced as GPR137. Its precise endogenous ligand and broader physiological role remain to be elucidated; however, its oncogenic potential is increasingly recognized.
N/A (No drugs identified; however, gene silencing via RNA interference has shown to inhibit cell proliferation and induce apoptosis in cancer cell lines.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 137 (GPR137).